This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tripep Ab. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Margaret Sällberg Chen
Introduction
Margaret Sällberg Chen is a prominent inventor based in Stockholm, Sweden. He has made significant contributions to the field of immunology, particularly in the development of T cell receptors that target hepatitis C virus (HCV). His work has the potential to advance therapeutic strategies for combating this viral infection.
Latest Patents
Margaret holds a patent for "T cell receptors specific for immunodominant CTL epitopes of HCV." This invention focuses on the discovery of several T cell receptors (TCRs) that are specific for an immunodominant CTL epitope of hepatitis C virus. The patent encompasses TCRs, DNAs encoding TCRs, methods of making TCRs, and methods of using TCRs to treat, prevent, or inhibit HCV proliferation. He has 1 patent to his name.
Career Highlights
Margaret Sällberg Chen is associated with Tripep AB, a company that specializes in developing innovative therapies for viral infections. His work at Tripep AB has been instrumental in advancing research in immunology and developing new treatment options for patients affected by HCV.
Collaborations
Due to space constraints, the details of his collaborations will not be included.
Conclusion
Margaret Sällberg Chen's contributions to immunology, particularly through his patent on T cell receptors for hepatitis C virus, highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to inspire advancements in the field of immunology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile